Sanofi to buy mRNA developer for $3.2 billion

Shares of Translate Bio Inc.
TBIO,
+5.46%
soared 29.8% in premarket trading on Tuesday after Sanofi
fr:snySNY,
+0.08%
said it will spend $3.2 billion to buy the developer of messenger RNA (mRNA) technologies. The U.S.-listed shares of Sanofi were…

Click here to view the original article.